-
181
Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
Published 2025-01-01“…We defined minimally adequate pharmacotherapy as antidepressant prescriptions filled with ≥ 84 days’ supply and adequate psychological treatment as ≥ 4 counselling/psychotherapy services. …”
Get full text
Article -
182
Use of Methadone for Neuropathic Pain
Published 2003-01-01“…Anticonvulsant and antidepressant treatments provide effective analgesia in up to 50% of patients with chronic neuropathic pain (2) and there is a growing body of high-quality evidence that controlled-release opioid analgesics provide substantial pain relief in a further subset of patients (3-6). …”
Get full text
Article -
183
Possibilities of Using Macrolepiota procera in the Production of Prohealth Food and in Medicine
Published 2022-01-01“…The data on other health-promoting properties and the possibilities of using these mushrooms in medicine were also compiled and summarized, taking into account their antibacterial, antioxidant, anti-inflammatory, regulatory, antidepressant, and anticancer effects. Moreover, the influence of various forms of processing and conservation of raw mushroom on its health-promoting properties was discussed. …”
Get full text
Article -
184
Cardiovascular Side Effects of Atomoxetine and Its Interactions with Inhibitors of the Cytochrome P450 System
Published 2011-01-01“…Atomoxetine is a phenoxypropylamine derivative and is structurally related to the antidepressant fluoxetine. The common side effects reported with the use of atomoxetine include mainly GI disturbances. …”
Get full text
Article -
185
Tramadol-Induced Mood Elevation in a Patient with No Previous Psychiatric History
Published 2018-01-01“…Tramadol is a powerful analgesic medication with antidepressant effects like venlafaxine. Hypomanic features were reported in patients with psychiatric history of mood disturbance when tramadol was prescribed for them. …”
Get full text
Article -
186
Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
Published 2019-01-01“…Currently available antidepressant drugs are notoriously problematic, with suboptimal remission rates and troubling side-effect profiles. …”
Get full text
Article -
187
New Therapeutic Targets for Mood Disorders
Published 2010-01-01“…The paper reviews data on new compounds that have shown antimanic or antidepressant effects in subjects with mood disorders, or similar effects in preclinical animal models. …”
Get full text
Article -
188
A Case of Almost Painless Herpes Zoster Presenting with Symptoms of Cystitis, Penile Numbness, and Acute Vestibular Failure
Published 2013-01-01“…Gabapentin and tricyclic antidepressant are effective in postherpetic neuralgia. …”
Get full text
Article -
189
Selective activation of SIGMAR1 in anterior cingulate cortex glutamatergic neurons facilitates comorbid pain in depression in male mice
Published 2025-01-01“…These results revealed a previously unknown neural mechanism for depression and pain comorbidity and provided new mechanistic insights into the antidepressive and analgesic effects of the disease.…”
Get full text
Article -
190
A Novel Drug-Drug Salt of Naproxen and Vortioxetine: Synthesis, Characterization, and Solubility Study
Published 2023-01-01“…Naproxen (NAP) is an aromatic propionic acid nonsteroidal anti-inflammatory drug, and vortioxetine (VOT) is a novel antidepressant drug. In this study, a new 1 : 1 drug-drug salt of NAP and VOT (namely, NAP-VOT) was designed and synthesized by liquid-assisted grinding and slow evaporation. …”
Get full text
Article -
191
Longitudinal Course of Illness in Congenitally Deaf Patient with Auditory Verbal Hallucination
Published 2022-01-01“…His psychotic symptoms decreased when his primary medication was changed from an antidepressant to antipsychotic drugs, based on the change of diagnosis. …”
Get full text
Article -
192
YELLOW CAMELLIAS: A REVIEW OF CHEMICAL CONSTITUENTS AND BIOLOGICAL ACTIVITIES
Published 2022-04-01“…Many pharmacological studies have proved that the total extracts, fractions, and isolated substances from yellow camellia species possess antioxidant, anticancer, hypolipidemic, hypoglycemic, antiallergic, hepatoprotective, neuroprotective, anxiolytic, and antidepressant activities. This review systematically summarizes recent research results in order to provide a comprehensive and up-to-date understanding of the chemical composition and biological activities of yellow camellia species, creating a basis for research of the yellow camellia species in Vietnam and development of new products from this source.…”
Get full text
Article -
193
Occurrence, properties and biological significance of pyroglutamyl peptides derived from different food sources
Published 2019-09-01“…Moreover, some health-promoting properties have been reported for pGlu peptides, including hepatoprotective, antidepressant and anti-inflammatory activities. However, the role of pGlu residue in the peptide bioactivity is not completely established, although the hydrophobic γ-lactam ring is thought to enhance the peptide stability against degradation by gastrointestinal proteases. …”
Get full text
Article -
194
Anxiety and depression in people with epilepsy during and one year after the COVID‐19 pandemic
Published 2025-02-01“…The only significant finding was that patients on anxiolytic or antidepressant medication had lower scores for anxiety and depression. …”
Get full text
Article -
195
Prediction of individual patient outcomes to psychotherapy vs medication for major depression
Published 2025-02-01“…Abstract Treatments for major depressive disorder (MDD) include antidepressant medications and evidence-based psychotherapies, which are approximately equally efficacious. …”
Get full text
Article -
196
Trichloroacetic Acid Ingestion: Self-Harm Attempt
Published 2017-01-01“…TCAAs are also abbreviated and referred to as TCAs, causing confusion with the psychiatric antidepressant drug class, especially among patients. …”
Get full text
Article -
197
Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update
Published 2022-07-01“…Related to its long-standing use as an antidepressant, the safety profile and pharmacokinetics of viloxazine are well understood. …”
Get full text
Article -
198
Chronic Tinnitus following Electroconvulsive Therapy
Published 2011-01-01“…A 43-year-old female with a 27-year history of obsessive-compulsive disorder and major depression had previously been treated with psychotherapy, antidepressant, and antipsychotic medications. …”
Get full text
Article -
199
Effect of Lorazepam on the Development of the Hairy Maggot Blow Fly, Chrysomya rufifacies (Macquart): Implication for Forensic Entomology
Published 2023-01-01“…Drugs can accumulate in fly larvae when they ingest the flesh of deceased persons and alter the normal development of the fly causing implications in calculating postmortem intervals. Lorazepam is an antidepressant generally used to treat anxiety. Larvae of Chrysomya rufifacies were fed on the beef liver mixed with lorazepam to study the effect of lorazepam on the developmental rate of larvae and to count delay in postmortem interval. …”
Get full text
Article -
200
New-Onset Panic, Depression with Suicidal Thoughts, and Somatic Symptoms in a Patient with a History of Lyme Disease
Published 2015-01-01“…During inpatient psychiatric hospitalization his psychiatric and physical symptoms did not improve with antidepressant and anxiolytic treatments. The patient’s panic attacks resolved after he was discharged and then, months later, treated with long-term antibiotics for suspected “chronic Lyme Disease” (CLD) despite having negative Lyme titers. …”
Get full text
Article